Literature DB >> 7678624

Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.

J Verwilghen1, P Vandenberghe, G Wallays, M de Boer, N Anthony, G S Panayi, J L Ceuppens.   

Abstract

The T cell surface molecules CD5 and CD28 have been shown to be receptors for accessory signals in T cell activation. We here demonstrate that in the absence of any other activating stimulus, simultaneous ligation of CD5 and CD28 by mAb induces polyclonal T cell activation. Immobilization of the anti-CD28 and anti-CD5 mAb was an essential requirement for T cell stimulation. This was done either through coating of the culture plates with goat anti-mouse Ig, or by coculture with mitomycin C-treated Fc gamma R-bearing P815 mouse mastocytoma cells. Most importantly, T cells could also be stimulated with B7, the natural ligand of CD28, and anti-CD5 presented on irradiated 3T6 mouse fibroblasts co-transfected with human Fc gamma RII and with B7. Neither immobilized mAb 9.3 (anti-CD28) nor any of four different anti-CD5 mAb were mitogenic as a sole stimulus. Immobilized mAb identifying CD4, CD7, or LFA-1 were not co-mitogenic with either mAb 9.3 or one of the anti-CD5 mAb. The T cell proliferation induced by cross-linking of CD5 and CD28 is IL-2-dependent, as was demonstrated by the cell-surface expression of the p55 chain of the IL-2R, the production of IL-2, and inhibition of the proliferative response by the anti-IL-2R mAb anti-Tac. CD5/CD28 ligation induced production of TNF-alpha, but not of IL-4, and did not induce modulation of the TCR/CD3 complex. Expression of IL-2R (p55) and of CD69 preferentially occurred on CD29-low naive cells, and indicated that about 50% of the cultured cells were activated. Cell proliferation was not increased by adding monocytes to the cultures and it was inhibited by PKC inhibitors (H7 and staurosporine) and by cyclosporine A. In conclusion, our data provide evidence for a pathway of Ag-independent T cell activation via CD5 and CD28, which preferentially stimulates native T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678624

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Chemokine receptor 7 (CCR7)-expression and IFNγ production define vaccine-specific canine T-cell subsets.

Authors:  Ashley N Hartley; Rick L Tarleton
Journal:  Vet Immunol Immunopathol       Date:  2015-02-07       Impact factor: 2.046

3.  Reactive arthritis-associated bacteria can stimulate lymphocyte proliferation in non-exposed individuals and newborns.

Authors:  F Chieco-Bianchi; K Hedley; T Weissensteiner; G S Panayi; G H Kingsley
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

4.  Expression and function of CD5 and CD28 in patients with rheumatoid arthritis.

Authors:  J Verwilghen; V Corrigall; R M Pope; R Rodrigues; G S Panayi
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.

Authors:  L M Osorio; M Rottenberg; M Jondal; S C Chow
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

6.  Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption.

Authors:  Y Teraki; N Moriya; T Shiohara
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.

Authors:  M Raab; M Yamamoto; C E Rudd
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.

Authors:  M Raab; Y C Cai; S C Bunnell; S D Heyeck; L J Berg; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.

Authors:  J H Lai; G Horvath; J Subleski; J Bruder; P Ghosh; T H Tan
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.

Authors:  M Kubin; M Kamoun; G Trinchieri
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.